Share Price and Basic Stock Data
Last Updated: November 18, 2025, 7:35 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Everlon Financials Ltd operates in the Non-Banking Financial Company (NBFC) sector, focusing on providing financial services without engaging in traditional banking. The company’s revenue trends reveal significant volatility, with sales reported at โน5.25 Cr for the fiscal year ending March 2023, which represented a substantial decline from โน35.40 Cr in March 2022. However, the revenue trajectory shows signs of recovery, with trailing twelve months (TTM) sales rising to โน16.81 Cr. Quarterly sales data indicates a fluctuating performance: from โน0.00 Cr in the initial quarters of FY 2023 to a peak of โน8.23 Cr by June 2025. This growth trajectory demonstrates the company’s potential to rebound and stabilize its revenue streams as it navigates a challenging financial landscape.
Profitability and Efficiency Metrics
Everlon Financials has faced challenges in profitability, as indicated by its net profit margin, which stood at -1.20%. The operating profit margin (OPM) was recorded at -4.25%, highlighting operational inefficiencies. Despite these obstacles, the company showed improvement in profitability metrics towards the end of the reporting period, with an operating profit of โน4.33 Cr for the fiscal year ending March 2025. The interest coverage ratio (ICR) was reported at 2.13x, indicating the ability to cover interest expenses. However, the cash conversion cycle (CCC) of 666.58 days raises concerns regarding operational efficiency and working capital management, suggesting that the company may struggle to convert its investments into cash effectively.
Balance Sheet Strength and Financial Ratios
Everlon Financials’ balance sheet exhibits a robust capital structure with zero borrowings, which is a significant strength compared to industry peers that often carry substantial debt. The company reported reserves of โน25.05 Cr as of March 2025, a notable increase from previous years, reflecting improved retained earnings. The price-to-book value (P/BV) ratio stood at 1.18x, indicating a premium valuation relative to its book value. However, the return on equity (ROE) was low at 4.69%, suggesting that the company is not efficiently utilizing its equity base to generate profits. The return on capital employed (ROCE) improved to 16.7%, reflecting better utilization of capital compared to earlier periods. This balance sheet strength positions Everlon favorably for potential investors, although the low ROE indicates room for improvement.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Everlon Financials reveals a high level of promoter confidence, with promoters holding 74.47% of the equity as of September 2023. This significant stake indicates a strong commitment from the founding members to the companyโs future. The public shareholding stood at 25.53%, which is relatively low compared to typical industry standards, suggesting limited retail investor interest. The number of shareholders decreased to 2,727 by September 2025, indicating a potential consolidation of shares among existing investors. This trend may reflect concerns regarding the company’s profitability and operational efficiency, impacting investor confidence and market perception. Overall, the high promoter stake may provide stability, but the declining public interest raises questions about broader market sentiment.
Outlook, Risks, and Final Insight
Looking ahead, Everlon Financials faces a mixed outlook characterized by both opportunities and risks. The company’s ability to stabilize revenues and improve profitability is crucial for restoring investor confidence. Key strengths include a zero-debt balance sheet and a committed promoter base, which can potentially lead to strategic decision-making. However, risks such as operational inefficiencies, indicated by a high cash conversion cycle and low net profit margins, could hinder growth. Additionally, the company must navigate a competitive NBFC landscape, which may impact its market position. Should Everlon enhance its operational efficiencies and capitalize on its financial strength, it could emerge as a more formidable player in the sector. Conversely, failure to address these challenges may lead to continued volatility in its financial performance.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Everlon Financials Ltd โ Key Insights and Financials.
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Minolta Finance Ltd | 12.7 Cr. | 1.27 | 1.91/0.89 | 1.07 | 0.00 % | 0.40 % | 0.09 % | 1.00 | |
| Money Masters Leasing & Finance Ltd | 10.9 Cr. | 1.09 | 11.4/1.03 | 32.2 | 1.57 | 0.00 % | 4.42 % | 3.94 % | 1.00 |
| Moneyboxx Finance Ltd | 457 Cr. | 139 | 269/130 | 80.1 | 0.00 % | 8.65 % | 0.58 % | 10.0 | |
| Moongipa Capital Finance Ltd | 14.4 Cr. | 15.8 | 37.9/15.0 | 10.8 | 26.6 | 0.00 % | 12.1 % | 9.43 % | 10.0 |
| Morarka Finance Ltd | 42.8 Cr. | 95.0 | 180/90.0 | 22.9 | 238 | 1.05 % | 2.46 % | 2.17 % | 10.0 |
| Industry Average | 29,161.97 Cr | 470.19 | 55.69 | 522.78 | 0.21% | 15.80% | 8.84% | 8.50 |
All Competitor Stocks of Everlon Financials Ltd โ Key Insights and Financials.
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 4.72 | 0.43 | 1.45 | 4.46 | 1.68 | 2.52 | 4.53 | 3.36 | 1.39 | 3.83 | 8.23 |
| Expenses | 0.06 | 0.13 | 2.50 | 0.43 | 0.06 | 3.14 | -0.01 | -2.10 | 2.47 | 2.78 | -3.15 | 9.11 | 8.58 |
| Operating Profit | -0.06 | -0.13 | 2.22 | 0.00 | 1.39 | 1.32 | 1.69 | 4.62 | 2.06 | 0.58 | 4.54 | -5.28 | -0.35 |
| OPM % | 47.03% | 0.00% | 95.86% | 29.60% | 100.60% | 183.33% | 45.47% | 17.26% | 326.62% | -137.86% | -4.25% | ||
| Other Income | 0.08 | 0.23 | -0.20 | 0.03 | 0.02 | 0.02 | 0.06 | 0.02 | 0.00 | 0.00 | 2.44 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.02 | 0.02 | 0.01 | 0.00 | 0.01 |
| Depreciation | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 | 0.03 | 0.02 | 0.02 | 0.03 | 0.03 | 0.02 |
| Profit before tax | 0.00 | 0.08 | 2.00 | 0.01 | 1.40 | 1.32 | 1.71 | 4.61 | 2.02 | 0.54 | 6.94 | -5.31 | -0.38 |
| Tax % | 0.00% | 6.00% | 6,300.00% | 33.57% | 33.33% | -43.27% | 19.31% | 2.48% | 18.52% | 35.73% | 7.16% | 7.89% | |
| Net Profit | 0.00 | 0.08 | 1.89 | -0.62 | 0.93 | 0.88 | 2.44 | 3.73 | 1.98 | 0.43 | 4.46 | -5.68 | -0.41 |
| EPS in Rs | 0.00 | 0.14 | 3.36 | -1.10 | 1.65 | 1.42 | 3.94 | 6.02 | 3.19 | 0.69 | 7.19 | -9.16 | -0.66 |
Last Updated: August 19, 2025, 3:46 pm
Below is a detailed analysis of the quarterly data for Everlon Financials Ltd โ Key Insights and Financials. based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 8.23 Cr.. The value appears strong and on an upward trend. It has increased from 3.83 Cr. (Mar 2025) to 8.23 Cr., marking an increase of 4.40 Cr..
- For Expenses, as of Jun 2025, the value is 8.58 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 9.11 Cr. (Mar 2025) to 8.58 Cr., marking a decrease of 0.53 Cr..
- For Operating Profit, as of Jun 2025, the value is -0.35 Cr.. The value appears strong and on an upward trend. It has increased from -5.28 Cr. (Mar 2025) to -0.35 Cr., marking an increase of 4.93 Cr..
- For OPM %, as of Jun 2025, the value is -4.25%. The value appears strong and on an upward trend. It has increased from -137.86% (Mar 2025) to -4.25%, marking an increase of 133.61%.
- For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Interest, as of Jun 2025, the value is 0.01 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.00 Cr. (Mar 2025) to 0.01 Cr., marking an increase of 0.01 Cr..
- For Depreciation, as of Jun 2025, the value is 0.02 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.03 Cr. (Mar 2025) to 0.02 Cr., marking a decrease of 0.01 Cr..
- For Profit before tax, as of Jun 2025, the value is -0.38 Cr.. The value appears strong and on an upward trend. It has increased from -5.31 Cr. (Mar 2025) to -0.38 Cr., marking an increase of 4.93 Cr..
- For Tax %, as of Jun 2025, the value is 7.89%. The value appears to be increasing, which may not be favorable. It has increased from 7.16% (Mar 2025) to 7.89%, marking an increase of 0.73%.
- For Net Profit, as of Jun 2025, the value is -0.41 Cr.. The value appears strong and on an upward trend. It has increased from -5.68 Cr. (Mar 2025) to -0.41 Cr., marking an increase of 5.27 Cr..
- For EPS in Rs, as of Jun 2025, the value is -0.66. The value appears strong and on an upward trend. It has increased from -9.16 (Mar 2025) to -0.66, marking an increase of 8.50.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 3:23 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 53.40 | 41.03 | 30.97 | 39.23 | 36.68 | 39.62 | 37.34 | 34.04 | 35.40 | 5.25 | 10.19 | 15.55 | 18.78 |
| Expenses | 52.16 | 39.90 | 30.55 | 38.53 | 35.95 | 39.49 | 36.74 | 32.53 | 34.62 | 3.11 | 1.06 | 11.22 | 21.98 |
| Operating Profit | 1.24 | 1.13 | 0.42 | 0.70 | 0.73 | 0.13 | 0.60 | 1.51 | 0.78 | 2.14 | 9.13 | 4.33 | -3.20 |
| OPM % | 2.32% | 2.75% | 1.36% | 1.78% | 1.99% | 0.33% | 1.61% | 4.44% | 2.20% | 40.76% | 89.60% | 27.85% | -17.04% |
| Other Income | 0.01 | 0.05 | 0.57 | 0.04 | 0.10 | 0.04 | 0.03 | -0.67 | 1.99 | 0.04 | 0.04 | 0.00 | 2.48 |
| Interest | 0.64 | 0.78 | 0.66 | 0.35 | 0.32 | 0.31 | 0.24 | 0.32 | 0.24 | 0.01 | 0.02 | 0.04 | 0.03 |
| Depreciation | 0.30 | 0.31 | 0.23 | 0.22 | 0.22 | 0.25 | 0.23 | 0.22 | 0.22 | 0.07 | 0.08 | 0.10 | 0.10 |
| Profit before tax | 0.31 | 0.09 | 0.10 | 0.17 | 0.29 | -0.39 | 0.16 | 0.30 | 2.31 | 2.10 | 9.07 | 4.19 | -0.85 |
| Tax % | 19.35% | 22.22% | 20.00% | 23.53% | 20.69% | 0.00% | 0.00% | 73.33% | 8.66% | 35.24% | 11.69% | 71.60% | |
| Net Profit | 0.25 | 0.07 | 0.08 | 0.14 | 0.23 | -0.39 | 0.16 | 0.08 | 2.11 | 1.35 | 8.00 | 1.19 | -3.80 |
| EPS in Rs | 0.45 | 0.12 | 0.14 | 0.25 | 0.41 | -0.69 | 0.28 | 0.14 | 3.75 | 2.40 | 12.90 | 1.92 | -6.13 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -72.00% | 14.29% | 75.00% | 64.29% | -269.57% | 141.03% | -50.00% | 2537.50% | -36.02% | 492.59% | -85.12% |
| Change in YoY Net Profit Growth (%) | 0.00% | 86.29% | 60.71% | -10.71% | -333.85% | 410.59% | -191.03% | 2587.50% | -2573.52% | 528.61% | -577.72% |
Everlon Financials Ltd โ Key Insights and Financials. has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -9% |
| 5 Years: | -16% |
| 3 Years: | -24% |
| TTM: | 27% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 33% |
| 5 Years: | 51% |
| 3 Years: | 42% |
| TTM: | -113% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 67% |
| 3 Years: | 63% |
| 1 Year: | -12% |
| Return on Equity | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 18% |
| 3 Years: | 21% |
| Last Year: | 5% |
Last Updated: September 5, 2025, 3:26 pm
No data available for the Balance Sheet data table.
Cash Flow - No data available for this post.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 16.88 | 17.88 | 24.63 | 16.38 | 31.54 | 19.44 | 9.58 | 31.74 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Days | 17.36 | 20.42 | 44.35 | 31.58 | 56.61 | 46.47 | 53.50 | 61.72 | 53.88 | 1,252.72 | 666.94 | |
| Days Payable | 7.29 | 8.08 | 8.95 | 6.72 | 11.82 | 4.78 | 5.40 | 7.92 | 0.26 | 3.00 | 0.35 | |
| Cash Conversion Cycle | 26.96 | 30.22 | 60.02 | 41.24 | 76.33 | 61.13 | 57.68 | 85.54 | 53.62 | 1,249.71 | 0.00 | 666.58 |
| Working Capital Days | -1.30 | -6.32 | 25.22 | 21.68 | 25.97 | 27.45 | 31.87 | 31.85 | 43.00 | 602.77 | 646.54 | 388.24 |
| ROCE % | 10.49% | 9.28% | 2.62% | 5.26% | 5.60% | -0.78% | 4.23% | 13.86% | 5.83% | 22.63% | 61.46% | 16.69% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 12 | Mar 11 | Mar 10 |
|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 1.63 | 1.13 | 1.95 |
| Diluted EPS (Rs.) | 1.63 | 1.13 | 1.95 |
| Cash EPS (Rs.) | 2.26 | 2.21 | 2.73 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 8.47 | 6.85 | 5.72 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 8.47 | 6.85 | 5.72 |
| Revenue From Operations / Share (Rs.) | 84.38 | 51.90 | 15.83 |
| PBDIT / Share (Rs.) | 2.49 | 3.21 | 3.53 |
| PBIT / Share (Rs.) | 1.86 | 2.13 | 2.76 |
| PBT / Share (Rs.) | 2.03 | 1.30 | 2.00 |
| Net Profit / Share (Rs.) | 1.63 | 1.13 | 1.95 |
| NP After MI And SOA / Share (Rs.) | 1.63 | 1.13 | 1.95 |
| PBDIT Margin (%) | 2.94 | 6.19 | 22.31 |
| PBIT Margin (%) | 2.20 | 4.11 | 17.41 |
| PBT Margin (%) | 2.40 | 2.50 | 12.61 |
| Net Profit Margin (%) | 1.93 | 2.18 | 12.33 |
| NP After MI And SOA Margin (%) | 1.93 | 2.18 | 12.33 |
| Return on Networth / Equity (%) | 19.27 | 16.51 | 34.11 |
| Return on Capital Employeed (%) | 10.47 | 17.68 | 25.48 |
| Return On Assets (%) | 6.11 | 5.53 | 16.03 |
| Long Term Debt / Equity (X) | 1.05 | 0.73 | 0.89 |
| Total Debt / Equity (X) | 1.73 | 1.15 | 0.89 |
| Asset Turnover Ratio (%) | 3.57 | 3.18 | 0.00 |
| Current Ratio (X) | 1.74 | 1.33 | 4.87 |
| Quick Ratio (X) | 0.65 | 0.68 | 3.45 |
| Inventory Turnover Ratio (X) | 10.05 | 12.88 | 0.00 |
| Interest Coverage Ratio (X) | 2.13 | 3.86 | 4.65 |
| Interest Coverage Ratio (Post Tax) (X) | 1.26 | 2.25 | 3.57 |
| Enterprise Value (Cr.) | 12.15 | 10.63 | 7.98 |
| EV / Net Operating Revenue (X) | 0.28 | 0.40 | 0.99 |
| EV / EBITDA (X) | 9.67 | 6.55 | 4.47 |
| MarketCap / Net Operating Revenue (X) | 0.11 | 0.26 | 0.71 |
| Price / BV (X) | 1.18 | 2.01 | 1.97 |
| Price / Net Operating Revenue (X) | 0.11 | 0.26 | 0.71 |
| EarningsYield | 0.16 | 0.08 | 0.17 |
After reviewing the key financial ratios for Everlon Financials Ltd โ Key Insights and Financials., here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 12, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 11) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 12, the value is 1.63. This value is below the healthy minimum of 5. It has increased from 1.13 (Mar 11) to 1.63, marking an increase of 0.50.
- For Diluted EPS (Rs.), as of Mar 12, the value is 1.63. This value is below the healthy minimum of 5. It has increased from 1.13 (Mar 11) to 1.63, marking an increase of 0.50.
- For Cash EPS (Rs.), as of Mar 12, the value is 2.26. This value is below the healthy minimum of 3. It has increased from 2.21 (Mar 11) to 2.26, marking an increase of 0.05.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 12, the value is 8.47. It has increased from 6.85 (Mar 11) to 8.47, marking an increase of 1.62.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 12, the value is 8.47. It has increased from 6.85 (Mar 11) to 8.47, marking an increase of 1.62.
- For Revenue From Operations / Share (Rs.), as of Mar 12, the value is 84.38. It has increased from 51.90 (Mar 11) to 84.38, marking an increase of 32.48.
- For PBDIT / Share (Rs.), as of Mar 12, the value is 2.49. This value is within the healthy range. It has decreased from 3.21 (Mar 11) to 2.49, marking a decrease of 0.72.
- For PBIT / Share (Rs.), as of Mar 12, the value is 1.86. This value is within the healthy range. It has decreased from 2.13 (Mar 11) to 1.86, marking a decrease of 0.27.
- For PBT / Share (Rs.), as of Mar 12, the value is 2.03. This value is within the healthy range. It has increased from 1.30 (Mar 11) to 2.03, marking an increase of 0.73.
- For Net Profit / Share (Rs.), as of Mar 12, the value is 1.63. This value is below the healthy minimum of 2. It has increased from 1.13 (Mar 11) to 1.63, marking an increase of 0.50.
- For NP After MI And SOA / Share (Rs.), as of Mar 12, the value is 1.63. This value is below the healthy minimum of 2. It has increased from 1.13 (Mar 11) to 1.63, marking an increase of 0.50.
- For PBDIT Margin (%), as of Mar 12, the value is 2.94. This value is below the healthy minimum of 10. It has decreased from 6.19 (Mar 11) to 2.94, marking a decrease of 3.25.
- For PBIT Margin (%), as of Mar 12, the value is 2.20. This value is below the healthy minimum of 10. It has decreased from 4.11 (Mar 11) to 2.20, marking a decrease of 1.91.
- For PBT Margin (%), as of Mar 12, the value is 2.40. This value is below the healthy minimum of 10. It has decreased from 2.50 (Mar 11) to 2.40, marking a decrease of 0.10.
- For Net Profit Margin (%), as of Mar 12, the value is 1.93. This value is below the healthy minimum of 5. It has decreased from 2.18 (Mar 11) to 1.93, marking a decrease of 0.25.
- For NP After MI And SOA Margin (%), as of Mar 12, the value is 1.93. This value is below the healthy minimum of 8. It has decreased from 2.18 (Mar 11) to 1.93, marking a decrease of 0.25.
- For Return on Networth / Equity (%), as of Mar 12, the value is 19.27. This value is within the healthy range. It has increased from 16.51 (Mar 11) to 19.27, marking an increase of 2.76.
- For Return on Capital Employeed (%), as of Mar 12, the value is 10.47. This value is within the healthy range. It has decreased from 17.68 (Mar 11) to 10.47, marking a decrease of 7.21.
- For Return On Assets (%), as of Mar 12, the value is 6.11. This value is within the healthy range. It has increased from 5.53 (Mar 11) to 6.11, marking an increase of 0.58.
- For Long Term Debt / Equity (X), as of Mar 12, the value is 1.05. This value exceeds the healthy maximum of 1. It has increased from 0.73 (Mar 11) to 1.05, marking an increase of 0.32.
- For Total Debt / Equity (X), as of Mar 12, the value is 1.73. This value exceeds the healthy maximum of 1. It has increased from 1.15 (Mar 11) to 1.73, marking an increase of 0.58.
- For Asset Turnover Ratio (%), as of Mar 12, the value is 3.57. It has increased from 3.18 (Mar 11) to 3.57, marking an increase of 0.39.
- For Current Ratio (X), as of Mar 12, the value is 1.74. This value is within the healthy range. It has increased from 1.33 (Mar 11) to 1.74, marking an increase of 0.41.
- For Quick Ratio (X), as of Mar 12, the value is 0.65. This value is below the healthy minimum of 1. It has decreased from 0.68 (Mar 11) to 0.65, marking a decrease of 0.03.
- For Inventory Turnover Ratio (X), as of Mar 12, the value is 10.05. This value exceeds the healthy maximum of 8. It has decreased from 12.88 (Mar 11) to 10.05, marking a decrease of 2.83.
- For Interest Coverage Ratio (X), as of Mar 12, the value is 2.13. This value is below the healthy minimum of 3. It has decreased from 3.86 (Mar 11) to 2.13, marking a decrease of 1.73.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 12, the value is 1.26. This value is below the healthy minimum of 3. It has decreased from 2.25 (Mar 11) to 1.26, marking a decrease of 0.99.
- For Enterprise Value (Cr.), as of Mar 12, the value is 12.15. It has increased from 10.63 (Mar 11) to 12.15, marking an increase of 1.52.
- For EV / Net Operating Revenue (X), as of Mar 12, the value is 0.28. This value is below the healthy minimum of 1. It has decreased from 0.40 (Mar 11) to 0.28, marking a decrease of 0.12.
- For EV / EBITDA (X), as of Mar 12, the value is 9.67. This value is within the healthy range. It has increased from 6.55 (Mar 11) to 9.67, marking an increase of 3.12.
- For MarketCap / Net Operating Revenue (X), as of Mar 12, the value is 0.11. This value is below the healthy minimum of 1. It has decreased from 0.26 (Mar 11) to 0.11, marking a decrease of 0.15.
- For Price / BV (X), as of Mar 12, the value is 1.18. This value is within the healthy range. It has decreased from 2.01 (Mar 11) to 1.18, marking a decrease of 0.83.
- For Price / Net Operating Revenue (X), as of Mar 12, the value is 0.11. This value is below the healthy minimum of 1. It has decreased from 0.26 (Mar 11) to 0.11, marking a decrease of 0.15.
- For EarningsYield, as of Mar 12, the value is 0.16. This value is below the healthy minimum of 5. It has increased from 0.08 (Mar 11) to 0.16, marking an increase of 0.08.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Everlon Financials Ltd โ Key Insights and Financials.:
- Net Profit Margin: 1.93%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 10.47% (Industry Average ROCE: 15.8%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 19.27% (Industry Average ROE: 8.84%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.26
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.65
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 55.69)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 1.73
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 1.93%